FTXH News and Press, First Trust Nasdaq Pharmaceuticals ETF From 04/21/21

This has been a long, long boom in the amount of money that's flowed into this sector, and I don't think I've ever seen anything like it in my own career. This has been VC money going into early-stage startups, it's been IPOs, it's been follow-on financing of already public companies....

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of thi...

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those ...

In our opinion, telehealth will remain the leading segment of the internet healthcare market as the market shifts away from in-person medical visits. According to Apple CEO Tim Cook, “I believe, if you zoom out into the future, and you look back, and you ask the question, ...

First Trust Nasdaq Pharmaceuticals ETF (FTXH) declares $0.0771/share quarterly dividend, 19.7% increase from prior dividend of $0.0644.Forward yield 1.21%Payable March 31; for shareholders of record March 26; ex-div March 25.See FTXH Dividend Scorecard, Yield Chart, & Dividend Growth. F...

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets. LeMaitre Vascular Inc. manufactures and distributes medical devices for the tre...

After a dramatic year of volatility, the U.S. stock market ended 2020 at record highs. Can this momentum continue this year? ESG investments clearly outperformed in 2020. 2021 should be a year of much better cash flow for companies. For further details see: A Stock Picke...

2020 was a busy year for global healthcare with unprecedented efforts to develop vaccines, treatments, and diagnostics for COVID-19. Deal flow in the sector continued to gain momentum in 2020, with M&A transactions and product licensing deals totalling five-year highs as large-cap...

First Trust Nasdaq Pharmaceuticals ETF (FTXH) declares $0.0644/share quarterly dividend, 50.5% increase from prior dividend of $0.0428.Forward yield 1.0%Payable Dec. 31; for shareholders of record Dec. 28; ex-div Dec. 24.See FTXH Dividend Scorecard, Yield Chart, & Dividend Growth. For f...

First Trust Nasdaq Pharmaceuticals ETF (FTXH) declares $0.0428/share quarterly dividend, -7.6% decrease from prior dividend of $0.0463.Forward yield 0.73%Payable Sept. 30; for shareholders of record Sept. 25; ex-div Sept. 24.See FTXH Dividend Scorecard, Yield Chart, & Dividend Growth. F...